Mary Ellen Coe - 31 Dec 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Mary Ellen Coe
Issuer symbol
MRK
Transactions as of
31 Dec 2025
Net transactions value
+$30,000
Form type
4
Filing time
05 Jan 2026, 12:16:53 UTC
Previous filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coe Mary Ellen Director ALPHABET INC., 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Kelly E. W. Grez as Attorney-in-Fact for Mary Ellen Coe 05 Jan 2026 0001691304

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 10 31 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Phantom Stock Award $30,000 +285 +0.98% $105.26 29,232 31 Dec 2025 Common Stock 285 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3 Holdings include shares acquired in dividend reinvestment transactions.